NCT03072706

Brief Summary

Total hip replacement is one of the most successful surgical procedures of modern times, with over 80,000 performed each year in the UK. However, up to 5% of all primary hip replacements need to be revised within the first 10 years, and in many cases malposition of the acetabular (hip socket) component is implicated in the early failure. The standard method of positioning the acetabular component is for the surgeon to be guided by a combination of the visible anatomical landmarks within the surgical field, and the wider environment of the operating theatre. The advent of 3D printing has led to the development of custom-made surgical guides which can be used during surgery, in order to assist the surgeon in the positioning of instruments and devices. These surgical guides are manufactured based on CT or MRI imaging, and are designed to clearly indicate to the surgeon the desired location and orientation of bony cuts and implant positions. This study will test the hypothesis that an acetabular alignment guide combined with three-dimensional CT-based planning using the Corin OPS™ (Optimised Positioning System), provides more accurate component alignment following primary total hip replacement compared with the current standard treatment, with the aim of improving patient outcomes and reducing the risk of complications of total hip replacement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

November 7, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2020

Completed
5.7 years until next milestone

Results Posted

Study results publicly available

February 24, 2026

Completed
Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

2.6 years

First QC Date

March 2, 2017

Results QC Date

April 20, 2022

Last Update Submit

February 4, 2026

Conditions

Keywords

hip replacementacetabulumanteversionpositionguide

Outcome Measures

Primary Outcomes (1)

  • Acetabular Cup Anteversion Angle

    The difference between planned and achieved acetabular cup anteversion assessed by post-operative CT scan

    6 weeks (+/- 2 weeks) post-surgery

Study Arms (2)

Standard group

ACTIVE COMPARATOR

2D X-ray templating technology

Other: 2D X-ray templating technology

Corin OPS™

EXPERIMENTAL

Corin Optimised Positioning System (OPS) Dynamic Hip Analysis

Device: Corin OPS™

Interventions

The OPS Dynamic Hip Analysis is a computer software package used to generate simulations of a total joint replacement from patient imaging. The dynamic simulation is used for operative planning, including implant selection, sizing and placement; and to create custom instruments or delivery specifications referencing the patient's anatomy and bio-mechanics. The simulation can also be used for the post-operative evaluation of joint performance.

Corin OPS™

Standard care where hip replacement is planned using 2D X-ray templating software

Also known as: Standard Care
Standard group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing an elective primary unilateral total hip replacement (THR) under the care of an orthopaedic consultant at University Hospitals Coventry and Warwickshire NHS Trust
  • Provision of written informed consent.
  • Male or Female aged 18-70 years.
  • Able and willing to comply with all study requirements.

You may not qualify if:

  • Those patients deemed by the treating clinician as unsuitable for an uncemented primary acetabular implant for reasons such as
  • Low demand patient
  • Osteoporosis
  • Significant acetabular bone loss
  • Patients with significant orthopaedic deformities (eg fused knee, hip or ankle).
  • Unable to undergo planning imaging (unable to stand or sit for X-rays, or to lie in a CT scanner).
  • Patients currently receiving ionising radiation treatment or scans for other medical conditions.
  • Previous entry in this trial (contralateral THR).
  • Participation in a clinical trial of an investigational medicinal product in the last 90 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Coventry and Warwickshire

Coventry, West Midlands, CV2 2DX, United Kingdom

Location

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Professor Richard King
Organization
University Hospitals Coventry and Warwickshire NHS Trust

Study Officials

  • Richard King, MBChB

    University Hospitals Coventry and Warwickshire NHS Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The patient assessor will be blinded to the patients' group allocation
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Model Details: Single-centre, patient-assessor blinded, parallel-group, randomised-controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2017

First Posted

March 7, 2017

Study Start

November 7, 2017

Primary Completion

June 26, 2020

Study Completion

June 26, 2020

Last Updated

February 24, 2026

Results First Posted

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made available to other researchers

Locations